The Europe Digital Therapeutics Market would witness market growth of 21.3% CAGR during the forecast period (2021-2027). Digital therapeutics is a term that refers to a section of digital health, which is a software driven evidence-based intervention.
There is a lot of potential in digital therapeutics to fulfil the unfulfilled requirements of patients, which traditional treatments & therapies could not fulfil. Thus, organizations that are using life science technologies to fill the gap between demand & supply of healthcare solutions along with faster product development would get more advantages than traditional life sciences enterprises.
Several companies across the industries are getting inspired and keen to explore the potential of the digital therapeutics market. Some technology giants are also planning to enter and transform the healthcare sector. Players are keen to know how digital therapeutics affect reimbursement policies and simultaneously exploring the way patient data collected via these products can be utilized to inform coverage. A few of the start-ups are also launching unique concepts to attract more investors.
Healthcare facilities across the world have a huge cost involved; many people could not afford a basic healthcare facility, which created the need for the solutions which can reduce healthcare costs. Digital therapeutics assist in decreasing the costs incurred in chronic diseases, by assisting patients or an insurance provider to monitor a person’s health status and also track it with the help of digital solutions. The cost of treatment of chronic diseases like diabetes has increased over the years. This increasing cost would be managed well by using digital therapeutics that is available by the providers to assist in managing diabetes. Digital therapeutics can help people in getting assistance for disease management and face the logistical challenges unwrapped by the doctors.
The Germany market dominated the Europe Respiratory Diseases Applications Market by Country 2020, thereby, achieving a market value of $109.9 million by 2027. The UK market is exhibiting a CAGR of 22.8% during (2021 - 2027). Additionally, The France market is poised to grow at a CAGR of 24.5% during (2021 - 2027).
Based on End Use, the market is segmented into Patients, Providers, Payers, Employers and Others. Based on Applications, the market is segmented into Diabetes, CNS Disease, Respiratory Diseases, Smoking Cessation, Obesity, CVD and others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Digital Therapeutics Market Size will Hit $14.5 Billion by 2027, at a CAGR of 21.8%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include ResMed, Inc. (Propeller Health), Teladoc Health, Inc. (Livongo Health), Noom, Inc., Omada Health, Inc., Welldoc, Inc., Canary Health, Mango Health, Inc. (TrialCard, Incorporated), 2Morrow, Inc., Pear Therapeutics, Inc., and Mindstrong, Inc.
Scope of the Study
Market Segments Covered in the Report:
By End Use
- Patients
- Providers
- Payers
- Employers
- Others
By Application
- Diabetes
- CNS Disease
- Respiratory Diseases
- Smoking Cessation
- Obesity
- CVD
- others
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- ResMed, Inc. (Propeller Health)
- Teladoc Health, Inc. (Livongo Health)
- Noom, Inc.
- Omada Health, Inc.
- Welldoc, Inc.
- Canary Health
- Mango Health, Inc. (TrialCard, Incorporated)
- 2Morrow, Inc.
- Pear Therapeutics, Inc.
- Mindstrong, Inc.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Digital Therapeutics Market, by End Use
1.4.2 Europe Digital Therapeutics Market, by Application
1.4.3 Europe Digital Therapeutics Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Restraints:
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Business Expansions
3.2.4 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2016-2020)
3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2017, Mar – 2021, Mar) Leading Players
Chapter 4. Europe Digital Therapeutics Market by End Use
4.1 Europe Patients Market by Country
4.2 Europe Providers Market by Country
4.3 Europe Payers Market by Country
4.4 Europe Employers Market by Country
4.5 Europe Other End Use Market by Country
Chapter 5. Europe Digital Therapeutics Market by Applications
5.1 Europe Diabetes Applications Market by Country
5.2 Europe CNS Disease Applications Market by Country
5.3 Europe Respiratory Diseases Applications Market by Country
5.4 Europe Smoking Cessation Applications Market by Country
5.5 Europe Obesity Applications Market by Country
5.6 Europe CVD Applications Market by Country
5.7 Europe Other Applications Market by Country
Chapter 6. Europe Digital Therapeutics Market by Country
6.1 Germany Digital Therapeutics Market
6.1.1 Germany Digital Therapeutics Market by End Use
6.1.2 Germany Digital Therapeutics Market by Applications
6.2 UK Digital Therapeutics Market
6.2.1 UK Digital Therapeutics Market by End Use
6.2.2 UK Digital Therapeutics Market by Applications
6.3 France Digital Therapeutics Market
6.3.1 France Digital Therapeutics Market by End Use
6.3.2 France Digital Therapeutics Market by Applications
6.4 Russia Digital Therapeutics Market
6.4.1 Russia Digital Therapeutics Market by End Use
6.4.2 Russia Digital Therapeutics Market by Applications
6.5 Spain Digital Therapeutics Market
6.5.1 Spain Digital Therapeutics Market by End Use
6.5.2 Spain Digital Therapeutics Market by Applications
6.6 Italy Digital Therapeutics Market
6.6.1 Italy Digital Therapeutics Market by End Use
6.6.2 Italy Digital Therapeutics Market by Applications
6.7 Rest of Europe Digital Therapeutics Market
6.7.1 Rest of Europe Digital Therapeutics Market by End Use
6.7.2 Rest of Europe Digital Therapeutics Market by Applications
Chapter 7. Company Profiles
7.1 ResMed, Inc. (Propeller Health)
7.1.1 Company Overview
7.1.1 Financial Analysis
7.1.2 Segmental and Regional Analysis
7.1.3 Research & Development Expense
7.1.4 Recent strategies and developments:
7.1.4.1 Approvals and Trials:
7.1.4.2 Partnerships, Collaborations, and Agreements:
7.2 Teladoc Health, Inc. (Livongo Health)
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Recent strategies and developments:
7.2.3.1 Partnerships, Collaborations, and Agreements:
7.2.3.2 Acquisition and Mergers:
7.3 Noom, Inc.
7.3.1 Company Overview
7.3.2 Recent strategies and developments:
7.3.2.1 Partnerships, Collaborations, and Agreements:
7.4 Omada Health, Inc.
7.4.1 Company Overview
7.4.2 Recent strategies and developments:
7.4.2.1 Partnerships, Collaborations, and Agreements:
7.4.2.2 Acquisition and Mergers:
7.4.2.3 Product Launches and Product Expansions:
7.5 Welldoc, Inc.
7.5.1 Company Overview
7.5.2 Recent strategies and developments:
7.5.2.1 Partnerships, Collaborations, and Agreements:
7.6 Canary Health
7.6.1 Company Overview
7.6.2 Recent strategies and developments:
7.6.2.1 Partnerships, Collaborations, and Agreements:
7.6.2.2 Business Expansions:
7.7 Mango Health, Inc. (TrialCard, Incorporated)
7.7.1 Company Overview
7.7.2 Recent strategies and developments:
7.7.2.1 Partnerships, Collaborations, and Agreements:
7.8 2Morrow, Inc.
7.8.1 Company Overview
7.9 Pear Therapeutics, Inc.
7.9.1 Company Overview
7.9.2 Recent strategies and developments:
7.9.2.1 Partnerships, Collaborations, and Agreements:
7.9.2.2 Acquisition and Mergers:
7.9.2.3 Product Launches and Product Expansions:
7.10. Mindstrong, Inc.
7.10.1 Company Overview
7.10.2 Recent strategies and developments:
7.10.2.1 Partnerships, Collaborations, and Agreements:
TABLE 1 Europe Digital Therapeutics Market, 2017 - 2020, USD Million
TABLE 2 Europe Digital Therapeutics Market, 2021 - 2027, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Digital Therapeutics Market
TABLE 4 Product Launches And Product Expansions– Digital Therapeutics Market
TABLE 5 Business Expansions– Digital Therapeutics Market
TABLE 6 Acquisition and Mergers– Digital Therapeutics Market
TABLE 7 Europe Digital Therapeutics Market by End Use, 2017 - 2020, USD Million
TABLE 8 Europe Digital Therapeutics Market by End Use, 2021 - 2027, USD Million
TABLE 9 Europe Patients Market by Country, 2017 - 2020, USD Million
TABLE 10 Europe Patients Market by Country, 2021 - 2027, USD Million
TABLE 11 Europe Providers Market by Country, 2017 - 2020, USD Million
TABLE 12 Europe Providers Market by Country, 2021 - 2027, USD Million
TABLE 13 Europe Payers Market by Country, 2017 - 2020, USD Million
TABLE 14 Europe Payers Market by Country, 2021 - 2027, USD Million
TABLE 15 Europe Employers Market by Country, 2017 - 2020, USD Million
TABLE 16 Europe Employers Market by Country, 2021 - 2027, USD Million
TABLE 17 Europe Other End Use Market by Country, 2017 - 2020, USD Million
TABLE 18 Europe Other End Use Market by Country, 2021 - 2027, USD Million
TABLE 19 Europe Digital Therapeutics Market by Applications, 2017 - 2020, USD Million
TABLE 20 Europe Digital Therapeutics Market by Applications, 2021 - 2027, USD Million
TABLE 21 Europe Diabetes Applications Market by Country, 2017 - 2020, USD Million
TABLE 22 Europe Diabetes Applications Market by Country, 2021 - 2027, USD Million
TABLE 23 Europe CNS Disease Applications Market by Country, 2017 - 2020, USD Million
TABLE 24 Europe CNS Disease Applications Market by Country, 2021 - 2027, USD Million
TABLE 25 Europe Respiratory Diseases Applications Market by Country, 2017 - 2020, USD Million
TABLE 26 Europe Respiratory Diseases Applications Market by Country, 2021 - 2027, USD Million
TABLE 27 Europe Smoking Cessation Applications Market by Country, 2017 - 2020, USD Million
TABLE 28 Europe Smoking Cessation Applications Market by Country, 2021 - 2027, USD Million
TABLE 29 Europe Obesity Applications Market by Country, 2017 - 2020, USD Million
TABLE 30 Europe Obesity Applications Market by Country, 2021 - 2027, USD Million
TABLE 31 Europe CVD Applications Market by Country, 2017 - 2020, USD Million
TABLE 32 Europe CVD Applications Market by Country, 2021 - 2027, USD Million
TABLE 33 Europe Other Applications Market by Country, 2017 - 2020, USD Million
TABLE 34 Europe Other Applications Market by Country, 2021 - 2027, USD Million
TABLE 35 Europe Digital Therapeutics Market by Country, 2017 - 2020, USD Million
TABLE 36 Europe Digital Therapeutics Market by Country, 2021 - 2027, USD Million
TABLE 37 Germany Digital Therapeutics Market, 2017 - 2020, USD Million
TABLE 38 Germany Digital Therapeutics Market, 2021 - 2027, USD Million
TABLE 39 Germany Digital Therapeutics Market by End Use, 2017 - 2020, USD Million
TABLE 40 Germany Digital Therapeutics Market by End Use, 2021 - 2027, USD Million
TABLE 41 Germany Digital Therapeutics Market by Applications, 2017 - 2020, USD Million
TABLE 42 Germany Digital Therapeutics Market by Applications, 2021 - 2027, USD Million
TABLE 43 UK Digital Therapeutics Market, 2017 - 2020, USD Million
TABLE 44 UK Digital Therapeutics Market, 2021 - 2027, USD Million
TABLE 45 UK Digital Therapeutics Market by End Use, 2017 - 2020, USD Million
TABLE 46 UK Digital Therapeutics Market by End Use, 2021 - 2027, USD Million
TABLE 47 UK Digital Therapeutics Market by Applications, 2017 - 2020, USD Million
TABLE 48 UK Digital Therapeutics Market by Applications, 2021 - 2027, USD Million
TABLE 49 France Digital Therapeutics Market, 2017 - 2020, USD Million
TABLE 50 France Digital Therapeutics Market, 2021 - 2027, USD Million
TABLE 51 France Digital Therapeutics Market by End Use, 2017 - 2020, USD Million
TABLE 52 France Digital Therapeutics Market by End Use, 2021 - 2027, USD Million
TABLE 53 France Digital Therapeutics Market by Applications, 2017 - 2020, USD Million
TABLE 54 France Digital Therapeutics Market by Applications, 2021 - 2027, USD Million
TABLE 55 Russia Digital Therapeutics Market, 2017 - 2020, USD Million
TABLE 56 Russia Digital Therapeutics Market, 2021 - 2027, USD Million
TABLE 57 Russia Digital Therapeutics Market by End Use, 2017 - 2020, USD Million
TABLE 58 Russia Digital Therapeutics Market by End Use, 2021 - 2027, USD Million
TABLE 59 Russia Digital Therapeutics Market by Applications, 2017 - 2020, USD Million
TABLE 60 Russia Digital Therapeutics Market by Applications, 2021 - 2027, USD Million
TABLE 61 Spain Digital Therapeutics Market, 2017 - 2020, USD Million
TABLE 62 Spain Digital Therapeutics Market, 2021 - 2027, USD Million
TABLE 63 Spain Digital Therapeutics Market by End Use, 2017 - 2020, USD Million
TABLE 64 Spain Digital Therapeutics Market by End Use, 2021 - 2027, USD Million
TABLE 65 Spain Digital Therapeutics Market by Applications, 2017 - 2020, USD Million
TABLE 66 Spain Digital Therapeutics Market by Applications, 2021 - 2027, USD Million
TABLE 67 Italy Digital Therapeutics Market, 2017 - 2020, USD Million
TABLE 68 Italy Digital Therapeutics Market, 2021 - 2027, USD Million
TABLE 69 Italy Digital Therapeutics Market by End Use, 2017 - 2020, USD Million
TABLE 70 Italy Digital Therapeutics Market by End Use, 2021 - 2027, USD Million
TABLE 71 Italy Digital Therapeutics Market by Applications, 2017 - 2020, USD Million
TABLE 72 Italy Digital Therapeutics Market by Applications, 2021 - 2027, USD Million
TABLE 73 Rest of Europe Digital Therapeutics Market, 2017 - 2020, USD Million
TABLE 74 Rest of Europe Digital Therapeutics Market, 2021 - 2027, USD Million
TABLE 75 Rest of Europe Digital Therapeutics Market by End Use, 2017 - 2020, USD Million
TABLE 76 Rest of Europe Digital Therapeutics Market by End Use, 2021 - 2027, USD Million
TABLE 77 Rest of Europe Digital Therapeutics Market by Applications, 2017 - 2020, USD Million
TABLE 78 Rest of Europe Digital Therapeutics Market by Applications, 2021 - 2027, USD Million
TABLE 79 Key Information – ResMed, Inc.
TABLE 80 Key Information – Teladoc Health, Inc.
TABLE 81 key information – Noom, Inc.
TABLE 82 Key Information – Omada Health, Inc.
TABLE 83 key Information – Welldoc, Inc.
TABLE 84 Key Information – Canary Health
TABLE 85 key information – Mango Health, Inc.
TABLE 86 Key Information – 2Morrow, Inc.
TABLE 87 Key Information – Pear Therapeutics, Inc.
TABLE 88 Key Information – Mindstrong, Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2016-2020)
FIG 4 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2017, Mar – 2021, Mar) Leading Players
FIG 5 Recent strategies and developments: Teladoc Health, Inc.
FIG 6 Recent strategies and developments: Omada Health, Inc.
FIG 7 Recent strategies and developments: Canary Health
FIG 8 Recent strategies and developments: Pear Therapeutics, Inc.